[1]
“THE TUMOR IMMUNE MICROENVIRONMENT AS A KEY DETERMINANT OF DISEASE PROGRESSION AND THERAPEUTIC RESPONSE IN HPV-ASSOCIATED CERVICAL CANCER”, PSSIR, vol. 3, no. 1, pp. 11–13, Jan. 2026, Accessed: Nov. 21, 2026. [Online]. Available: https://universalconference.us/index.php/pssir/article/view/6365